Introducing Kardia 12L: The first of its kind 12-lead portable ECG | Learn More

AliveCor Logo

Our Products

AFib Screening
Data Integration Solutions
KardiaCare Plus
KardiaComplete
Kardia 12L

New

KardiaMobile 6L
AliveCor K1000
KardiaStation
KardiaPro
Kardia ECG Devices

Our Solutions

Health Systems
Clinical Trials
Payors
Employers
OEMs
Veterans Affairs

About

Leadership
Mission
Clinical Research
Our AI
For Consumers
The Human Component Film
Newsroom
(855) 338-8800
AliveCor Logo
AliveCor Logo
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
    • (855) 338-8800
    • Mission
    • Careers
    • Research
    • Newsroom
    • FAQs
    • User Manuals
    • Compatibility
    • Shipping
    • (855) 338-8800
    • KardiaMobile Card
    • KardiaMobile 6L
    • KardiaMobile
    • KardiaCare
    • International
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • Privacy Policy
  • Security
  • Telehealth Informed Consent
  • Terms
  • Accessibility

©2024 AliveCor, Inc. All Rights Reserved. Patents www.alivecor.com/patents. AliveCor and Kardia are trademarks of AliveCor, Inc. in the United States and other countries. Apple is a trademark of Apple, Inc. registered in the U.S. and other countries. App Store is a service mark of Apple, Inc. Android is a trademark of Google Inc. Google Play is a trademark of Google Inc.

Go Back
U.K. Hospitals to Use New AliveCor Heart Monitor During Heart Rhythm
SAN FRANCISCO Calif., June 3, 2013

Week June 3-9

Availability of innovative mobile ECG monitor to aid in the screening and monitoring of heart conditions

AliveCor, Inc. announced today that more than 20 hospitals in the United Kingdom will use the AliveCor Heart Monitor during the 10th annual Heart Rhythm Awareness Week June 3–9, sponsored by Arrhythmia Alliance, The Heart Rhythm Charity in the U.K.

Heart Rhythm Week is an annual awareness week that aims to give everyone the opportunity to raise awareness and promote better understanding of heart rhythm disorders. While manual pulse checks have long been a focus of educational activity during the week, this will be the first time that hospitals/GP surgeries – from the Highlands to Jersey – will use the new ECG technology.

The AliveCor Heart Monitor is the first CE-marked mobile device-based ECG monitor that is used to record, display, store, and transfer single-channel ECG rhythms. The device snaps onto the back of an iPhone and is used with the corresponding AliveECG app. Recorded rhythm strips can be of any duration, and are stored in the app and securely in the cloud for reviewing, analysis, and printing through AliveCor’s website. Cloud storage is compliant with EU Data Privacy & Safe Harbor in the European Union. ECG data is accessible anytime, anywhere.

“Helping people understand their pulse and how it can be a warning sign for a potentially fatal heart rhythm disorder has long been a cornerstone of our educational activity and forms the basis of one of our key campaigns: Know Your Pulse .” said Trudie Lobban MBE, Founder and CEO of Arrhythmia Alliance and AF Association. “During World Heart Rhythm Week and beyond, we will be encouraging healthcare professionals and the public to realize the potential of technology such as the AliveCor ECG monitor to ‘ Know Your Pulse’ .”

Arrhythmias currently affect more than 2 million people in the U.K. with an additional 200,000 individuals diagnosed each year. The AliveCor Heart Monitor brings an easy and cost-effective way for physicians, patients and health-conscious individuals to record clinical quality, single-channel ECG rhythms. The portability and convenience of the device gives instant access when symptoms arise, potentially aiding faster management and therapy decisions to reduce the risk of stroke.

Francis White has joined the AliveCor Team as General Manager EU to manage and grow the European business. White comes with a wealth of experience in the healthcare industry. He spent the last 10 years at Medtronic, Inc. and most recently was the Business Director of Cardiac Rhythm Disease Management, U.K. & Ireland. He will be directing the expansion of AliveCor’s products and services throughout Europe in 2013 and building from the successful introduction of the Heart Monitor in the U.S. earlier this year.

“Francis brings a proven track record of success in Europe in the medical device space,” said Dan Sullivan, President & CEO at AliveCor. “Francis is a welcome addition for AliveCor as we continue to expand our services and offerings, supporting our mission of, everyone’s health at their fingertips.”

Let's transform cardiovascular care together

If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.